Quantum Pharmaceuticals

In-vitro study of DLX5 Ligands

Gulnara Yamanbaeva — Thu, 26 Jan 2012 14:44:09 +0000

The manuscript entitled “Transcription Factor DLX5 As a New Target for Promising Antitumor Agents” by the Quantum Team. The reference: R. A. Timakhov1,2,3*, P. O. Fedichev1, A. A. Vinnik1, J.... Related posts:

High Throughput Screening of Transcription factor DLX5

High Throughput Screening of Transcription factor DLX5

Gulnara Yamanbaeva — Thu, 26 Jan 2012 14:23:10 +0000

The manuscript entitled “Transcription Factor DLX5 As a New Target for Promising Antitumor Agents” by the Quantum Team The reference: R. A. Timakhov1,2,3*, P. O. Fedichev1, A. A. Vinnik1, J.... Related posts:

MA/p17 HIV matrix protein is a promising target for drug discovery

Peter Fedichev, Quantum CTO — Tue, 20 Dec 2011 14:00:43 +0000

As a result of the analysis of HIV virus targets, the most conservative among all the possible HIV-1 virus target protein—p17/MA (see figure)—was selected. This is a matrix (structural) protein,... Related posts:

Experimental evidence of the ferroelectric phase transition near the $λ-$point in liquid water

Peter Fedichev, Quantum CTO — Thu, 25 Aug 2011 16:34:31 +0000

The manuscript entitled “Experimental evidence of the ferroelectric phase transition near the $λ-$point in liquid water” has just been accepted to JETP Letters (Russian Journal of Experimental and Theoretical Physics... Related posts:

Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo

Peter Fedichev, Quantum CTO — Tue, 09 Aug 2011 06:18:11 +0000

The manuscript entitled “” by the Quantum Team has been accepted to PLoS Currents Influenza. The reference: Fedichev, Peter; Timakhov, Roman; Pyrkov, Tim; Getmantsev, Evgeny; Vinnik, Andrey. Structure-based drug design... Related posts: